The LuLac Edition #615, Oct. 26th, 2008
PHOTO INDEX: OBAMA FOR PRESIDENT BUTTON, HAZLETON MAYOR LOU BARLETTA AND STATE SENATOR ROBERT MELLOW.
Senator Bob Mellow had a news conference Sunday at the Veteran's Center in Scranton talking about and John McCain’s plan to privatize Social Security would mean for area seniors given the recent roller coaster on the stock market. John McCain has repeatedly said he supports privatizing Social Security. Mellow and McGrath will hold the news conference in advance of McCain’s stop in Pottsville on Monday. Mellow was joined by Lackawanna County Chair Harry McGrath. His surrogate appearance on this issue only accentuates the talk that Mellow might be a candidate for the Democratic nomination for Governor in 2010.
The Times Leader endorsed Senator Obama today over John McCain. The editorial board voted 5 to 3 in favor of the Illinois Senator. Publisher Richard Connor had a dissenting vote and said so in his opinion column in the sunday edition. The Leader also gave the nod to Hazleton Mayor Lou Barletta saying that he was more than a one issue candidate. While acknowledging Kanjorski's depth and intelligence as a member of Congress, Kanjorski's allocation of federal funds toward family members seemed the death knell for the Congressman with the editorial board.
ELECTION TOP 40
MEDICARE # 6
Obama’s plan for the Medicare program calls for lower drug prices and more choices for long-term care. He does not plan to reduce benefits or eligibility. Instead, he hopes to strengthen care for those enrolled in the program.
McCain proposes payment reform and eliminating fraud and abuse. McCain plans to promote a payment system that rewards coordinated and quality focused care. He wants to eliminate Medicare fraud and abuse and ensure drug premiums for the wealthiest Americans are not being subsidized by the middle class. McCain also hopes to implement a new generation of treatment models that better manage chronic care conditions and greater use of health information technology. McCain said drug costs can be reduced by allowing greater use of generics, including bio-generics.